Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dzmitry Viatushka"'
Autor:
Dzmitriy Zhurkin, Elmira Gurbanova, Jonathon R. Campbell, Dick Menzies, Svetlana Setkina, Hennadz Hurevich, Varvara Solodovnikova, Dzmitry Viatushka, Alan Altraja, Alena Skrahina
Publikováno v:
ERJ Open Research, Vol 8, Iss 2 (2022)
Bedaquiline is now considered a first-line medicine for treatment of rifampicin-resistant tuberculosis (RR-TB). We evaluated the safety of treatment with bedaquiline for longer than 190 days in individuals with RR-TB under programmatic conditions. In
Externí odkaz:
https://doaj.org/article/f96b8d3f622d45fd9570bfeec4316a7f
Autor:
Simone Tunesi, Damien Le Dû, Gina Gualano, Joan-Pau Millet, Aliaksandr Skrahin, Graham Bothamley, Xavier Casas, Delia Goletti, Christoph Lange, Maria Musso, Fabrizio Palmieri, Valérie Pourcher, Christophe Rioux, Alena Skrahina, Nicolas Veziris, Dzmitry Viatushka, Mathilde Jachym-Fréchet, Lorenzo Guglielmetti, Dhiba Marigot-Outtandy, Xavier Lescure, Marie Dubert, Yazdan Yazdanpanah, Eric Caumes, Pascaline Choinier, Elie Haddad, Jakub Kowalczyk, Hélène Laurichesse, Olivier Lesens, Alexandra Aubry, Isabelle Bonnet, Florence Morel
Publikováno v:
Journal of Infection. 84:834-872
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f50f65b66b1953d61c88fad55724dc24
https://doi.org/10.1016/j.jinf.2022.03.004
https://doi.org/10.1016/j.jinf.2022.03.004
Autor:
Lorenzo Guglielmetti, Christophe Rioux, Christoph Lange, Simone Tunesi, Esgmyc, Valérie Pourcher, Maria Musso, Mathilde Jachym-Frechet, Joan-Pau Millet, Fabrizio Palmieri, Gina Gualano, Aliaksandr Skrahin, Tbnet, Alena Skrahina, Dzmitry Viatushka, Damien Le Dû, Nicolas Veziris, Xavier Casas, Graham H. Bothamley, Delia Goletti
Concomitant treatment for chronic hepatitis C virus infection and multidrug-resistant tuberculosis is safe and effective.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1112129104e93c33128ac7016289c25
https://doi.org/10.1101/2021.10.16.21265043
https://doi.org/10.1101/2021.10.16.21265043
Autor:
Svetlana Setkina, Andrei Dadu, Hennadz Hurevich, Varvara Solodovnikova, Dzmitry Viatushka, Masoud Dara, Dennis Falzon, Alena Skrahina, George Sakvarelidze, Pierpaolo de Colombani, Liudmila Zhylevich, Valiantsin Rusovich
Publikováno v:
10.2 Tuberculosis.
Outcomes of treatment for multidrug-resistant tuberculosis (MDR-TB) remain poor worldwide. In MDR-TB patients starting treatment in 2012 in Belarus, only 54% completed it successfully while in 22% treatment failed, 11% died and 13% were lost to follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20d046c9833c34a03ddda7c73d2f5745
https://doi.org/10.1183/13993003.congress-2016.pa2682
https://doi.org/10.1183/13993003.congress-2016.pa2682